Diet & Multiple Sclerosis

A healthy and balanced diet is essential for controling diseases such as multiple sclerosis. Here are the latest discoveries pertaining to diet and this disease.

February 25, 2021
Open Access

The CYP2R1 Enzyme: Structure, Function, Enzymatic Properties and Genetic Polymorphism.

Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Société Canadienne Des Sciences Pharmaceutiques
Amelia Nathania DongChin Eng Ong
February 24, 2021

Diet-dependent regulation of TGFβ impairs reparative innate immune responses after demyelination.

Nature Metabolism
Mar Bosch-QueraltMikael Simons
February 24, 2021

The Efficacy of Ketogenic Therapies in the Clinical Management of People with Neurodegenerative Disease: A Systematic Review.

Advances in Nutrition
Lauren S DewsburyGenevieve Z Steiner
February 20, 2021

The relative contributions of obesity, vitamin D, leptin, and adiponectin to multiple sclerosis risk: A Mendelian randomization mediation analysis.

Multiple Sclerosis : Clinical and Laboratory Research
Adil HarroudSergio E Baranzini
February 16, 2021

Gastrointestinal motility disorders in neurologic disease.

The Journal of Clinical Investigation
Michael Camilleri
February 16, 2021

Vitamin D Changes Expression of DNA Repair Genes in the Patients with Multiple Sclerosis.

Roya AmirinejadMehrdad Behmanesh
February 13, 2021


Wiadomości lekarskie : organ Polskiego Towarzystwa Lekarskiego
Monika Adamczyk-SowaMichał Kępiński
February 12, 2021
Open Access

Nutraceuticals against Oxidative Stress in Autoimmune Disorders.

Carmen MannucciSebastiano Gangemi
February 11, 2021

Gut Microbiota Changes in Experimental Autoimmune Encephalomyelitis and Cuprizone Mice Models.

ACS Chemical Neuroscience
Laura MolesDavid Otaegui
February 8, 2021
Open Access

Effect of CSF1R Inhibitor on Glial Cells Population and Remyelination in The Cuprizone Model

Fatemeh TahmasebiIraj Ragerdi Kashani
February 7, 2021
Open Access

Does the High Prevalence of Vitamin D Deficiency in African Americans Contribute to Health Disparities?

Bruce N AmesWalter C Willett
February 6, 2021

Self-reported use of vitamin D supplements is associated with higher physical quality of life scores in multiple sclerosis.

Multiple Sclerosis and Related Disorders
Steve Simpson-YapGeorge A Jelinek
February 6, 2021
Open Access

Age-dependent VDR peak DNA methylation as a mechanism for latitude-dependent multiple sclerosis risk.

Epigenetics & Chromatin
Lawrence T C OngGrant P Parnell
February 4, 2021

Dietary patterns and associations with health outcomes in Australian people with multiple sclerosis.

European Journal of Clinical Nutrition
Claudia H MarckIngrid van der Mei
February 3, 2021

Awareness of Saudi community toward multiple sclerosis in Qassim Region, Saudi Arabia.

Neurosciences : the Official Journal of the Pan Arab Union of Neurological Sciences
Nourah A Al-HamdanManal A Al-Batanony
February 1, 2021
Open Access

The effect of fingolimod on regulatory T cells in a mouse model of brain ischaemia.

Journal of Neuroinflammation
Kyle MaloneChristian Waeber

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Acute Hemorrhagic Leukoencephalitis

Acute hemorrhagic leukoencephalitis is a rare form of acute disseminated encephalomyelitis characterized by acute inflammation in the brain and spinal cord that causes demyelination and bleeding. It is often fatal, although treatment with immunosuppressives and plasma exchange can be helpful. Find the latest research on acute hemorrhagic leukoencephalitis here.

© 2021 Meta ULC. All rights reserved